Dr. Eric Winer, director @yalecancer.bsky.social & president, physician-in-chief of Smilow Cancer Hospital, shares his personal story of #hemophilia, the powerful lesson of human connection in medicine, & why he believes 'getting close to patients helps you become a better doctor.'
bit.ly/4ifUGXw
📌Excited to share our publication evaluating TP53 alterations with a closer look at TP53 Y220C alteration in metastatic breast cancer @jco-asco.bsky.social
ascopubs.org/doi/10.1200/...
@maryamlustberg.bsky.social @adrianakahn.bsky.social @yalecancer.bsky.social
Three years after receiving funding from Women’s Health Research at Yale, @pamelakunzmd.bsky.social & her interdisciplinary research team completed a study that reveals important and significant differences between women & men with neuroendocrine neoplasms (NENs).
medicine.yale.edu/innovations-...
Dr. Amer Zeidan explains how balancing disease-related factors with real-world patient needs helps care teams present treatment options and support shared decision-making in #AML. #leukemia
www.targetedonc.com/view/zeidan-...
@yale-hematology.bsky.social @targetedonc.bsky.social
New research from Dr. Susan Gueble and @ranjitbindra.bsky.social supports KL-50 as a candidate therapy for MGMT-deficient tumors, demonstrating activity in preclinical models of MGMT-deficient #coloncancer, #melanoma, and #lungcancer.
medicine.yale.edu/cancer/publi...
Thank you Dr. David Cescon of Princess Margaret Cancer Centre for presenting our #GrandRounds / Kingsbury Lecture in Breast Cancer, sharing insights on emerging data on #ctDNA monitoring in metastatic #breastcancer.
➡️Watch his full talk: youtube.com/watch?v=CyRc...
Register today to attend the Ella T. Grasso Memorial Conference in Gynecologic Oncology:
🗓️Wednesday, November 11
📍Yale West Campus, West Haven
⏰8am-2:30pm
🎤Keynote: Dr. Ursula Matulonis @danafarber.bsky.social
➡️For more info and to RSVP: bit.ly/4hNCJOV
Congratulations to Dr. Daniel Boffa, named Chair of the American College of Surgeons #ACS Commission on Cancer (CoC). Among his priorities as chair is helping hospital teams deliver high-quality #cancer care amid financial and workforce challenges.
facs.org/media-center...
We are excited to welcome Dr. David Cescon for our #GrandRounds and Kingsbury Lecture in Breast Cancer presenting "All You Need is Blood? ctDNA in Breast Cancer: Building Evidence Toward Personalized Care."
Join us in Smilow Auditorium or via Zoom, today at 12pm: bit.ly/4rDRDLW
Celebrating a powerful day at our annual Metastatic Breast Cancer Conference. We were honored to welcome so many patients, caregivers, researchers, and physicians together for a day of connection, education, and hope. đź©· @maryamlustberg.bsky.social @adrianakahn.bsky.social
Dr. Kathleen Suozzi talks with Dr. Eric Winer tonight at 7:30pm on #YaleCancerAnswers. They review differences between #basalcell and #squamouscell carcinomas, and how everyone can protect their skin and still enjoy the outdoors.
🎧Listen live #WNPR
đź’»Listen later #ApplePodcasts, #Spotify, #YouTube
With shortages of the #HPV vaccine, Dr. Daniel DiMaio
@yalegenetics.bsky.social and his lab developed a genetic platform to cultivate HPV and identify viral variants, establishing the first system to use genetic selection for HPV.
medicine.yale.edu/cancer/news-...
@oncoalert.bsky.social
A revolutionary #cancer treatment that extracts a patient’s own immune cells, and re-engineers them to recognize tumor targets, CAR-T therapy, is now being studied at Yale for autoimmune diseases including lupus, multiple sclerosis, and scleroderma.
medicine.yale.edu/cancer/news-...
Beatrice Katsnelson shared analysis of 2,186 patients with #NSCLC, noting KEAP1 & SMARCA4 tumor mutations predicted development of bone mets. Findings suggest molecular profiling could identify high-risk pts and increase surveillance strategies. #ASTRO26
@astro-org.bsky.social @oncoalert.bsky.social
Dr. Victor Lee shared that patients with #prostatecancer & TP53 mutations had higher pathologic lymph node involvement. Noting incorporating TP53 mutational status into risk stratification models could improve patient selection for elective nodal irradiation. #ASTRO26 @oncoalert.bsky.social
Dr. Mary-Kate Lawlor presented new data #ASTRO26 showing in 81 patients with stage III uterine serous carcinoma, #EBRT significantly improved pelvic control + OS vs vaginal brachytherapy alone (4-year OS 87% vs. 55%) without increased toxicity.
@astro-org.bsky.social @oncoalert.bsky.social
Dr. Victor Lee presents an analysis of patients with stage I–III #breastcancer through MSK-CHORD #ASTRO26 showing TP53 mutations were associated with development of brain mets, suggesting TP53 mutational status may enhance risk stratification.
@astro-org.bsky.social @oncoalert.bsky.social
Congratulations to Dr. Christopher Rodman, recipient of @nanets.bsky.social Clinical Investigator Scholarship (NCIS) Award for: "Radiomics, Deep Learning, and Digital Pathology to Identify Biomarkers of Response & Resistance to Capecitabine/Temozolomide in Advanced Pancreatic Neuroendocrine Tumors.”
Dr. Mary Kate Lawlor presented a Quick Pitch presentation earlier today at #ASTRO26 on "Morbidity of Pelvic Recurrence in Stage 3 Uterine Serous Carcinoma."
amportal.astro.org/sessions/qp-29…
@astro-org.bsky.social
Dr. Victor Lee will present during a Scientific Symposium this afternoon #ASTRO26 on "TP53 Mutations in Primary Breast Tumors Predict Brain Metastases: Insights from the MSK CHORD Cohort."
amportal.astro.org/sessions/ss-40…
@astro-org.bsky.social
